Quest Healthcare plans new pharma unit in Hosur
Quest Healthcare is planning to set up a bulk drug unit in Hosur SIPCOT Industrial complex in Tamil Nadu. The project involves setting up of […]
Month: November 2017
Natco Pharma plans expansion programme in Manali
Natco Pharma is planning to expand its production unit in Vaikadu village in Manali near Chennai in Tamil Nadu. The project involves expanding bulk drug […]
Emmenar Pharma plans expansion programme
Emmenar Pharma Pvt Ltd is planning an expansion programme at its unit in Turkhal Khanpur village in Hatnoor Mandal in Medak district of Telangana. The […]
Prism Industries plans bulk drug unit in Kalamsar
Prism Industries Ltd is planning to expand its bulk drug unit in Kalamsar village in Khambhat Taluk in Anand district of Gujarat. The project involves […]
Spentica Life Science plans new unit in Hadala
Spentica Life Science is planning to set up a bulk drugs unit in Hadala village in Rajkot district of Gujarat. The project involves setting up […]
Ajanta Pharma launches Clonidine Hydrochloride ER tablet in USA
Ajanta Pharma received US FDA approval and has launched Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma […]
Zydus Cadila receives USFDA approval for minocycline hydrochloride
Zydus Cadila has received final USFDA approval to market minocycline hydrochloride extended release tablets used to treat acne. The company will market the drug in […]
Glenmark Pharma launches Kwitz – to quit smoking habit
Glenmark Pharmaceuticals has launched Kwitz, a medically approved nicotine replacement therapy for smokers. The Nicotine gum will be available in two variants. Kwitz 2mg will […]
DRL launches Clofarbine injection in US Markets
Dr. Reddy s Laboratories Ltd has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the United States market. The company […]
Cadila receives USFDA approval for candesartan cilextil
Zydus Cadila has received final USFDA approval to market candesartan cilexetil tablets used for treatment of hypertension. The company will market the drug in the […]